Retraction:  SAMMSON  drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/&#x03B2;-catenin activation

Xiaopeng Li; Ming Li; JiaLi Chen; Hua Dai; Liang Wang; Ying Xiong; Yuanbin Zhong; Lunli Zhang

doi:10.18632/oncotarget.28307

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation

PDF | How to cite

Oncotarget. 2022; 13:1201-1201. https://doi.org/10.18632/oncotarget.28307

Metrics: PDF 705 views | ?

Xiaopeng Li^1,*, Ming Li^1,*, JiaLi Chen², Hua Dai³, Liang Wang¹, Ying Xiong¹, Yuanbin Zhong¹ and Lunli Zhang¹

¹Department of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China
²Department of Function, JiangXi Children’s Hospital, Nanchang, JiangXi 330006, China
³Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China
^*These authors have contributed equally to this work

Published: November 2, 2022

Copyright: © 2022 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Figure 6B contains an image previously published in an earlier paper from another journal. The authors have been unable to retrieve their original experimental data, nor can they produce the necessary ethics approval documentation. Based on these deficiencies, all authors have agreed to retract this paper from Oncotarget.

Original article: Oncotarget. 2017; 8:103785–103796. DOI: https://doi.org/10.18632/oncotarget.21792

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28307

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation